PUBLISHER: Allied Market Research | PRODUCT CODE: 1641734
PUBLISHER: Allied Market Research | PRODUCT CODE: 1641734
Cell Culture Hydrogel Market By Type of Hydrogel, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2024-2035
The cell culture hydrogel market was valued at $400.0 million in 2023 and is estimated to reach $2,136.7 million by 2035, exhibiting a CAGR of 15.0% from 2024 to 2035.
Cell culture hydrogel is a three-dimensional, water-rich polymeric materials designed to mimic the extracellular matrix (ECM) environment for culturing cells in vitro. These hydrogels provide structural support, biochemical cues, and mechanical properties essential for maintaining cellular function, proliferation, and differentiation. They are commonly used in biomedical research, including tissue engineering, regenerative medicine, and drug discovery.
Increase in focus on stem cell therapies and research is a key factors that has fueled the demand for hydrogels, which support stem cell growth and differentiation by mimicking natural cellular environments. In addition, the transition from 2D to 3D cell cultures for drug screening, organoid development, and regenerative medicine has significantly increased the demand for hydrogels. Studies have shown that organoid cultures supported by synthetic hydrogels with tunable mechanical properties enhance reproducibility and mimic organ-like structures more accurately compared to traditional Matrigel scaffolds. Moreover, rising applications in drug discovery and development fuel the growth of the market. This is attributed to the fact that hydrogels enable the development of 3D models for high-throughput drug screening, enhancing their adoption by pharmaceutical and biotechnology industries. Furthermore, rise in need for advanced in vitro models to study chronic diseases like cancer, cardiovascular conditions, and diabetes is fueling the demand for hydrogels in biomedical research. A 2023 study published by the World Health Organization revealed that approximately 41 million individuals die each year due to chronic diseases. Rise in adoption of organ-on-a-chip technologies, which often incorporate hydrogels to simulate tissue microenvironments, further propels the market. However, requirement for tailoring hydrogel properties, such as stiffness, porosity, and degradation rate, to suit specific applications demands technical expertise and time, which acts as a barrier for the market growth. Moreover, availability of alternative 3D culture methods such as microcarrier-based cell cultures or scaffold-free methods like spheroids, can pose challenges to the market growth. On the contrary, innovations in hydrogel formulations, such as smart hydrogels with tunable properties and stimuli-responsive behavior, are expanding their functionality and applications. Rise in research and clinical efforts in tissue engineering and regenerative medicine are boosting the demand for hydrogels, which serve as key biomaterials for creating functional tissue constructs. Such developments are expected to offer lucrative opportunities for the expansion of the global market during the forecast period.
The cell culture hydrogel market is segmented into type of hydrogel, application, end user, and region. By type of hydrogel, the market is segmented into natural hydrogels, synthetic hydrogels, hybrid hydrogels. By application, the market is segmented into cancer and stem cell research, tissue engineering and regenerative medicine, drug discovery and toxicology testing, and others. By end user, the market is segregated into pharmaceutical and biotechnology companies, CROs, research institution, and others. Region wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and Rest of LAMEA).
Key Findings
Depending on type of hydrogel, the synthetic hydrogels segment dominated the share, in terms of share, in 2023, and is expected to register the highest CAGR from 2024 to 2035.
On the basis of application, the tissue engineering & regenerative medicine segment garnered the largest share in 2023; however, the cancer & stem cell research segment is expected to grow at the highest CAGR during the forecast period.
By end user, the pharmaceutical and biotechnology companies segment was the major shareholder in 2023; however, the CROs segment is anticipated to exhibit the highest CAGR during the forecast period.
Region wise, North America was the largest shareholder in the global cell culture hydrogel market in 2023; however, Asia-Pacific is anticipated to register the highest CAGR during the forecast period.
Competitive Analysis
The key players that operate in the global cell culture hydrogel market are Corning Incorporated, Merck KGaA, Humabiologics, Inc, Cell Guidance Systems, TheWell Bioscience Inc., CD Bioparticles, BICO, PELOBIOTECH GmbH, UPM, and Cellendes GmbH. These players have adopted expansion, agreement, partnership, and collaboration as their key strategies to strengthen their foothold in the global market
Key Benefits for Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cell culture hydrogel market analysis from 2023 to 2035 to identify the prevailing cell culture hydrogel market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the cell culture hydrogel market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global cell culture hydrogel market trends, key players, market segments, application areas, and market growth strategies.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Market share analysis of players by products/segments
- New Product Development/ Product Matrix of Key Players
- Additional company profiles with specific to client's interest
- Expanded list for Company Profiles
- Historic market data
Key Market Segments
By Type of Hydrogel
- Synthetic Hydrogels
- Hybrid Hydrogels
- Natural Hydrogels
By Application
- Cancer and Stem Cell Research
- Tissue Engineering and Regenerative Medicine
- Drug Discovery and Toxicology Testing
- Others
By End User
- Research Institutions
- Others
- Pharmaceutical and Biotechnology Companies
- CROs
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players:
- Corning Incorporated
- Merck KGaA
- Humabiologics, Inc
- UPM
- PELOBIOTECH GmbH
- CD Bioparticles
- Cell Guidance Systems
- BICO
- TheWell Bioscience Inc.
- Cellendes GmbH
TABLE OF CONTENTS
CHAPTER 1: INTRODUCTION
- 1.1. Report description
- 1.2. Key market segments
- 1.3. Key benefits to the stakeholders
- 1.4. Research methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
- 3.1. Market definition and scope
- 3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
- 3.3. Porter's five forces analysis
- 3.3.1. Moderate bargaining power of suppliers
- 3.3.2. Moderate threat of new entrants
- 3.3.3. Moderate threat of substitutes
- 3.3.4. Moderate intensity of rivalry
- 3.3.5. Moderate bargaining power of buyers
- 3.4. Market dynamics
- 3.4.1. Drivers
- 3.4.1.1. Applications in drug discovery and toxicology testing
- 3.4.1.2. Rise in prevalence of chronic diseases and aging population
- 3.4.1.3. Rise in demand for 3D cell culture
- 3.4.2. Restraints
- 3.4.2.1. Lack of a skilled workforce
- 3.4.3. Opportunities
- 3.4.3.1. High growth potential in emerging markets
- 3.4.3.2. Advancements in biotechnology and life sciences
- 3.4.1. Drivers
CHAPTER 4: CELL CULTURE HYDROGEL MARKET, BY TYPE OF HYDROGEL
- 4.1. Overview
- 4.1.1. Market size and forecast
- 4.2. Natural Hydrogels
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
- 4.3. Synthetic Hydrogels
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country
- 4.4. Hybrid Hydrogels
- 4.4.1. Key market trends, growth factors and opportunities
- 4.4.2. Market size and forecast, by region
- 4.4.3. Market share analysis by country
CHAPTER 5: CELL CULTURE HYDROGEL MARKET, BY APPLICATION
- 5.1. Overview
- 5.1.1. Market size and forecast
- 5.2. Cancer and Stem Cell Research
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
- 5.3. Tissue Engineering and Regenerative Medicine
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
- 5.4. Drug Discovery and Toxicology Testing
- 5.4.1. Key market trends, growth factors and opportunities
- 5.4.2. Market size and forecast, by region
- 5.4.3. Market share analysis by country
- 5.5. Others
- 5.5.1. Key market trends, growth factors and opportunities
- 5.5.2. Market size and forecast, by region
- 5.5.3. Market share analysis by country
CHAPTER 6: CELL CULTURE HYDROGEL MARKET, BY END USER
- 6.1. Overview
- 6.1.1. Market size and forecast
- 6.2. Pharmaceutical and Biotechnology Companies
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by region
- 6.2.3. Market share analysis by country
- 6.3. CROs
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by region
- 6.3.3. Market share analysis by country
- 6.4. Research Institutions
- 6.4.1. Key market trends, growth factors and opportunities
- 6.4.2. Market size and forecast, by region
- 6.4.3. Market share analysis by country
- 6.5. Others
- 6.5.1. Key market trends, growth factors and opportunities
- 6.5.2. Market size and forecast, by region
- 6.5.3. Market share analysis by country
CHAPTER 7: CELL CULTURE HYDROGEL MARKET, BY REGION
- 7.1. Overview
- 7.1.1. Market size and forecast By Region
- 7.2. North America
- 7.2.1. Key market trends, growth factors and opportunities
- 7.2.2. Market size and forecast, by Type of Hydrogel
- 7.2.3. Market size and forecast, by Application
- 7.2.4. Market size and forecast, by End User
- 7.2.5. Market size and forecast, by country
- 7.2.5.1. U.S.
- 7.2.5.1.1. Market size and forecast, by Type of Hydrogel
- 7.2.5.1.2. Market size and forecast, by Application
- 7.2.5.1.3. Market size and forecast, by End User
- 7.2.5.2. Canada
- 7.2.5.2.1. Market size and forecast, by Type of Hydrogel
- 7.2.5.2.2. Market size and forecast, by Application
- 7.2.5.2.3. Market size and forecast, by End User
- 7.2.5.3. Mexico
- 7.2.5.3.1. Market size and forecast, by Type of Hydrogel
- 7.2.5.3.2. Market size and forecast, by Application
- 7.2.5.3.3. Market size and forecast, by End User
- 7.3. Europe
- 7.3.1. Key market trends, growth factors and opportunities
- 7.3.2. Market size and forecast, by Type of Hydrogel
- 7.3.3. Market size and forecast, by Application
- 7.3.4. Market size and forecast, by End User
- 7.3.5. Market size and forecast, by country
- 7.3.5.1. Germany
- 7.3.5.1.1. Market size and forecast, by Type of Hydrogel
- 7.3.5.1.2. Market size and forecast, by Application
- 7.3.5.1.3. Market size and forecast, by End User
- 7.3.5.2. France
- 7.3.5.2.1. Market size and forecast, by Type of Hydrogel
- 7.3.5.2.2. Market size and forecast, by Application
- 7.3.5.2.3. Market size and forecast, by End User
- 7.3.5.3. UK
- 7.3.5.3.1. Market size and forecast, by Type of Hydrogel
- 7.3.5.3.2. Market size and forecast, by Application
- 7.3.5.3.3. Market size and forecast, by End User
- 7.3.5.4. Italy
- 7.3.5.4.1. Market size and forecast, by Type of Hydrogel
- 7.3.5.4.2. Market size and forecast, by Application
- 7.3.5.4.3. Market size and forecast, by End User
- 7.3.5.5. Spain
- 7.3.5.5.1. Market size and forecast, by Type of Hydrogel
- 7.3.5.5.2. Market size and forecast, by Application
- 7.3.5.5.3. Market size and forecast, by End User
- 7.3.5.6. Rest of Europe
- 7.3.5.6.1. Market size and forecast, by Type of Hydrogel
- 7.3.5.6.2. Market size and forecast, by Application
- 7.3.5.6.3. Market size and forecast, by End User
- 7.4. Asia-Pacific
- 7.4.1. Key market trends, growth factors and opportunities
- 7.4.2. Market size and forecast, by Type of Hydrogel
- 7.4.3. Market size and forecast, by Application
- 7.4.4. Market size and forecast, by End User
- 7.4.5. Market size and forecast, by country
- 7.4.5.1. Japan
- 7.4.5.1.1. Market size and forecast, by Type of Hydrogel
- 7.4.5.1.2. Market size and forecast, by Application
- 7.4.5.1.3. Market size and forecast, by End User
- 7.4.5.2. China
- 7.4.5.2.1. Market size and forecast, by Type of Hydrogel
- 7.4.5.2.2. Market size and forecast, by Application
- 7.4.5.2.3. Market size and forecast, by End User
- 7.4.5.3. Australia
- 7.4.5.3.1. Market size and forecast, by Type of Hydrogel
- 7.4.5.3.2. Market size and forecast, by Application
- 7.4.5.3.3. Market size and forecast, by End User
- 7.4.5.4. India
- 7.4.5.4.1. Market size and forecast, by Type of Hydrogel
- 7.4.5.4.2. Market size and forecast, by Application
- 7.4.5.4.3. Market size and forecast, by End User
- 7.4.5.5. South Korea
- 7.4.5.5.1. Market size and forecast, by Type of Hydrogel
- 7.4.5.5.2. Market size and forecast, by Application
- 7.4.5.5.3. Market size and forecast, by End User
- 7.4.5.6. Rest of Asia-Pacific
- 7.4.5.6.1. Market size and forecast, by Type of Hydrogel
- 7.4.5.6.2. Market size and forecast, by Application
- 7.4.5.6.3. Market size and forecast, by End User
- 7.5. LAMEA
- 7.5.1. Key market trends, growth factors and opportunities
- 7.5.2. Market size and forecast, by Type of Hydrogel
- 7.5.3. Market size and forecast, by Application
- 7.5.4. Market size and forecast, by End User
- 7.5.5. Market size and forecast, by country
- 7.5.5.1. Brazil
- 7.5.5.1.1. Market size and forecast, by Type of Hydrogel
- 7.5.5.1.2. Market size and forecast, by Application
- 7.5.5.1.3. Market size and forecast, by End User
- 7.5.5.2. Saudi Arabia
- 7.5.5.2.1. Market size and forecast, by Type of Hydrogel
- 7.5.5.2.2. Market size and forecast, by Application
- 7.5.5.2.3. Market size and forecast, by End User
- 7.5.5.3. South Africa
- 7.5.5.3.1. Market size and forecast, by Type of Hydrogel
- 7.5.5.3.2. Market size and forecast, by Application
- 7.5.5.3.3. Market size and forecast, by End User
- 7.5.5.4. Rest of LAMEA
- 7.5.5.4.1. Market size and forecast, by Type of Hydrogel
- 7.5.5.4.2. Market size and forecast, by Application
- 7.5.5.4.3. Market size and forecast, by End User
CHAPTER 8: COMPETITIVE LANDSCAPE
- 8.1. Introduction
- 8.2. Top winning strategies
- 8.3. Product mapping of top 10 player
- 8.4. Competitive dashboard
- 8.5. Competitive heatmap
- 8.6. Top player positioning, 2023
CHAPTER 9: COMPANY PROFILES
- 9.1. Corning Incorporated
- 9.1.1. Company overview
- 9.1.2. Key executives
- 9.1.3. Company snapshot
- 9.1.4. Operating business segments
- 9.1.5. Product portfolio
- 9.1.6. Business performance
- 9.2. Merck KGaA
- 9.2.1. Company overview
- 9.2.2. Key executives
- 9.2.3. Company snapshot
- 9.2.4. Operating business segments
- 9.2.5. Product portfolio
- 9.2.6. Business performance
- 9.2.7. Key strategic moves and developments
- 9.3. Humabiologics, Inc
- 9.3.1. Company overview
- 9.3.2. Key executives
- 9.3.3. Company snapshot
- 9.3.4. Operating business segments
- 9.3.5. Product portfolio
- 9.3.6. Key strategic moves and developments
- 9.4. BICO
- 9.4.1. Company overview
- 9.4.2. Key executives
- 9.4.3. Company snapshot
- 9.4.4. Operating business segments
- 9.4.5. Product portfolio
- 9.4.6. Business performance
- 9.5. TheWell Bioscience Inc.
- 9.5.1. Company overview
- 9.5.2. Key executives
- 9.5.3. Company snapshot
- 9.5.4. Operating business segments
- 9.5.5. Product portfolio
- 9.5.6. Key strategic moves and developments
- 9.6. CD Bioparticles
- 9.6.1. Company overview
- 9.6.2. Key executives
- 9.6.3. Company snapshot
- 9.6.4. Operating business segments
- 9.6.5. Product portfolio
- 9.7. PELOBIOTECH GmbH
- 9.7.1. Company overview
- 9.7.2. Key executives
- 9.7.3. Company snapshot
- 9.7.4. Operating business segments
- 9.7.5. Product portfolio
- 9.8. Cell Guidance Systems
- 9.8.1. Company overview
- 9.8.2. Key executives
- 9.8.3. Company snapshot
- 9.8.4. Operating business segments
- 9.8.5. Product portfolio
- 9.9. UPM
- 9.9.1. Company overview
- 9.9.2. Key executives
- 9.9.3. Company snapshot
- 9.9.4. Operating business segments
- 9.9.5. Product portfolio
- 9.9.6. Business performance
- 9.9.7. Key strategic moves and developments
- 9.10. Cellendes GmbH
- 9.10.1. Company overview
- 9.10.2. Key executives
- 9.10.3. Company snapshot
- 9.10.4. Operating business segments
- 9.10.5. Product portfolio
